Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Juni 2018 10:01 ET | Quelle: Zealand Pharma

Zealand Pharma presents two dasiglucagon milestone studies at the 78th Scientific Sessions of the American Diabetes Association (ADA)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press Release - No. 17/2018 Zealand...
23. Juni 2018 10:00 ET | Quelle: Zealand Pharma

Survey demonstrating underuse of glucagon rescue kits in type 1 diabetes patients to be presented at the ADA's 78th Scientific Sessions

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press Release - No. 16/2018 Survey...
31. Mai 2018 05:10 ET | Quelle: Zealand Pharma

Zealand Pharma will attend the Jefferies Global Healthcare Conference on June 5-8, 2018 in New York

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press release - No. 13 / 2018 ...
31. Mai 2018 05:09 ET | Quelle: Zealand Pharma

Zealand announces amendments to its Articles of Association following the granting of warrants

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Company announcement - No. 17/2018 ...
28. Mai 2018 05:19 ET | Quelle: Zealand Pharma

Zealand Pharma reports completion of the second and pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Company Announcement - No. 16/2018 ...
22. Mai 2018 05:09 ET | Quelle: Zealand Pharma

Zealand grants new warrants under employee warrant program

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Company announcement - No. 15/2018 ...
16. Mai 2018 09:00 ET | Quelle: Zealand Pharma

Zealand Pharma - Interim report for the first quarter of 2018

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Company announcement - No. 14 / 2018 ...
14. Mai 2018 06:56 ET | Quelle: Zealand Pharma

Zealand hosts conference call on May 16 at 4 pm CET/10 am EDT to present first quarter results 2018

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press Release - No. 12 / 2018 ...
02. Mai 2018 06:27 ET | Quelle: Zealand Pharma

Zealand Pharma to attend Deutsche Bank Securities 43rd Annual Health Care Conference, in Boston on May 8, 2018

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press release - No 11 / 2018 ...
27. April 2018 01:33 ET | Quelle: Zealand Pharma

Zealand announces net sales of Soliqua® 100/33 and Lyxumia®/Adlyxin® for the first quarter of 2018

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Company announcement - No. 13/2018 ...

Vorherige Seite

Nächste Seite